The prospects for pharma in the MINT emerging countries of Mexico, Indonesia, Nigeria and Turkey.
MINT: opportunities in ‘frontier’ markets?
MINT countries: what the opportunities may be for pharma and healthcare.
New frontiers in pharma: is ‘MINT’ the next ‘BRIC’?
Pharma markets ripe for development in Latin America.
Tapping Latin America’s healthcare market